CellaVision AB (publ) (STO: CEVI)
Sweden flag Sweden · Delayed Price · Currency is SEK
229.00
+1.50 (0.66%)
Jan 21, 2025, 9:39 AM CET

CellaVision AB Revenue

CellaVision AB had revenue of 178.66M SEK in the quarter ending September 30, 2024, with 6.41% growth. This brings the company's revenue in the last twelve months to 737.16M, up 17.20% year-over-year. In the year 2023, CellaVision AB had annual revenue of 677.29M with 5.94% growth.

Revenue (ttm)
737.16M
Revenue Growth
+17.20%
P/S Ratio
7.36
Revenue / Employee
3.23M
Employees
228
Market Cap
5.43B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023677.29M37.95M5.94%
Dec 31, 2022639.34M73.79M13.05%
Dec 31, 2021565.55M94.11M19.96%
Dec 31, 2020471.44M9.67M2.09%
Dec 31, 2019461.77M96.96M26.58%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Swedish Orphan Biovitrum AB 25.44B
Getinge AB 33.59B
Sectra AB 3.14B
Camurus AB 1.69B
Medicover AB 22.60B
Vitrolife AB 3.56B
Bonesupport Holding AB 814.46M
Elekta AB 17.72B
Revenue Rankings

CellaVision AB News

More News